Analysis of three encephalitis cases with double positive for N-methyl-D-aspartate receptor and myelinating oligodendrocyte glycoprotein antibodies

ZHU Lin; JIANG Li; YU Long; WU Jian; YIN Mengmei; HUANG Junwen; MA Cancan

doi:10.7619/jcmp.20233266

Journal of Clinical Medicine in Practice > 2024 > 28(2): 49-54, 59. > DOI: 10.7619/jcmp.20233266

ZHU Lin, JIANG Li, YU Long, WU Jian, YIN Mengmei, HUANG Junwen, MA Cancan. Analysis of three encephalitis cases with double positive for N-methyl-D-aspartate receptor and myelinating oligodendrocyte glycoprotein antibodies[J]. Journal of Clinical Medicine in Practice, 2024, 28(2): 49-54, 59. DOI: 10.7619/jcmp.20233266

Citation:

PDF (2358 KB)

Analysis of three encephalitis cases with double positive for N-methyl-D-aspartate receptor and myelinating oligodendrocyte glycoprotein antibodies

1.
Department of Neurology, School of Clinical Medicine of Yangzhou University, Subei People's Hospital Affiliated to Yangzhou University, Yangzhou, Jiangsu, 225000
2.
Department of Geriatrics, School of Clinical Medicine of Yangzhou University, Subei People's Hospital Affiliated to Yangzhou University, Yangzhou, Jiangsu, 225000
3.
Department of Imaging, School of Clinical Medicine of Yangzhou University, Subei People's Hospital Affiliated to Yangzhou University, Yangzhou, Jiangsu, 225000

More Information

Received Date: October 14, 2023
Revised Date: December 13, 2023
Available Online: January 25, 2024

Graphical Abstract

Abstract

Abstract

Objective
To observe the clinical manifestations of 3 cases with myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease and anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis antibody overlapping syndrome (MNOS), aiming to expand the understanding of the clinical spectrum of such syndromes.
Methods
Retrospective analysis was performed on the data of 3 patients with MNOS who were positive for both MOG antibodies and NMDAR antibodies. Clinical features, neuroimaging characteristics, and outcomes were collected, and cell-based assay (CBA) technique was used for diagnosis.
Results
One case presented both positive MOG antibodies and NMDAR antibodies, but the clinical manifestations were typical symptoms of anti-NMDAR encephalitis. In one case, the clinical and cranial magnetic resonance imaging (MRI) features of demyelinating disease recurred after anti-NMDAR encephalitis, with atypical symptoms of MNOS such as numbness and weakness in limbs, blurred vision, and diplopia. The last case presented both positive MOG antibodies and NMDAR antibodies, but the clinical manifestations were typical symptoms of anti-NMDAR encephalitis. In MNOS, MOG antibody-associated disease and anti-NMDAR encephalitis may appear simultaneously or sequentially, with epilepsy being the most common symptom. Cranial MRI findings showed that the patients presented and mainly involved supratentorial lesions, which may also involve the brainstem, but no spinal cord lesions were found. All patients showed slightly abnormal cerebrospinal fluid. Patients showed a good response to first-line immunotherapy during the acute phase of the disease, with a favorable prognosis. But most patients were prone to relapse.
Conclusion
In MNOS patients, anti-NMDAR encephalitis may present with clinical and(or)MRI features of demyelinating disease simultaneously or sequentially. The clinical manifestations of patients are complex and diverse. Patients with atypical symptoms require to improving the understanding of MNOS and timely treatment.
- myelin oligodendrocyte glycoprotein,
- anti-N-methyl-D-aspartate receptor,
- encephalitis,
- overlap syndrome

FullText(HTML)

References (23)

References

[1]	REINDL M, WATERS P. Myelin oligodendrocyte glycoprotein antibodies in neurological disease[J]. Nat Rev Neurol, 2019, 15(2): 89-102. doi: 10.1038/s41582-018-0112-x
[2]	中华医学会神经病学分会神经感染性疾病与脑脊液细胞学学组. 中国自身免疫性脑炎诊治专家共识(2022年版)[J]. 中华神经科杂志, 2022, 55(9): 931-949. doi: 10.3760/cma.j.cn113694-20220219-00118
[3]	FAN S Y, XU Y, REN H T, et al. Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis[J]. Mult Scler Relat Disord, 2018, 20: 144-152. doi: 10.1016/j.msard.2018.01.007
[4]	TITULAER M J, HÖFTBERGER R, ⅡZUKA T, et al. Overlapping demyelinating syndromes and anti-N-methyl-D-aspartate receptor encephalitis[J]. Ann Neurol, 2014, 75(3): 411-428. doi: 10.1002/ana.24117
[5]	DING J Y, LI X Y, TIAN Z Y. Clinical features of coexisting anti-NMDAR and MOG antibody-associated encephalitis: a systematic review and meta-analysis[J]. Front Neurol, 2021, 12: 711376. doi: 10.3389/fneur.2021.711376
[6]	FU J, PENG L L, YANG Y, et al. Case report: overlapping syndrome mimicking infectious meningoencephalitis in a patient with coexistent MOG, NMDAR, mGluR5 antibody positivity[J]. Front Immunol, 2022, 13: 919125. doi: 10.3389/fimmu.2022.919125
[7]	LI S S, WANG M J, LI H C, et al. Case report: overlapping syndrome of anti-NMDAR encephalitis and MOG inflammatory demyelinating disease in a patient with human herpesviruses 7 infection[J]. Front Immunol, 2022, 13: 799454. doi: 10.3389/fimmu.2022.799454
[8]	CHEN W B, LI Q, WANG T, et al. Overlapping syndrome of anti-N-methyl-D-aspartate receptor encephalitis and anti-myelin oligodendrocyte glycoprotein inflammatory demyelinating diseases: a distinct clinical entity?[J]. Mult Scler Relat Disord, 2021, 52: 103020. doi: 10.1016/j.msard.2021.103020
[9]	孙明明, 周欢粉, 徐全刚, 等. 髓鞘少突胶质细胞糖蛋白抗体阳性视神经炎合并抗N-甲基-D-天冬氨酸受体脑炎1例[J]. 中华眼科杂志, 2022, 58(9): 719-721. doi: 10.3760/cma.j.cn112142-20211106-00522
[10]	ZHANG S J, YANG Y, LIU W Y, et al. Clinical characteristics of anti-N-methyl-d-aspartate receptor encephalitis overlapping with demyelinating diseases: a review[J]. Front Immunol, 2022, 13: 857443. doi: 10.3389/fimmu.2022.857443
[11]	MARTINEZ-HERNANDEZ E, GUASP M, GARCÍA-SERRA A, et al. Clinical significance of anti-NMDAR concurrent with glial or neuronal surface antibodies[J]. Neurology, 2020, 94(22): e2302-e2310.
[12]	SHU H, DING M Q, SHANG P, et al. Myelin oligodendrocyte glycoprotein antibody associated cerebral cortical encephalitis: case reports and review of literature[J]. Front Hum Neurosci, 2021, 15: 782490.
[13]	FUJIMORI J, TAKAHASHI T, KANEKO K, et al. Anti-NMDAR encephalitis may develop concurrently with anti-MOG antibody-associated bilateral medial frontal cerebral cortical encephalitis and relapse with elevated CSF IL-6 and CXCL13[J]. Mult Scler Relat Disord, 2021, 47: 102611. doi: 10.1016/j.msard.2020.102611
[14]	VALENCIA-SANCHEZ C, GUO Y, KRECKE K N, et al. Cerebral cortical encephalitis in myelin oligodendrocyte glycoprotein antibody-associated disease[J]. Ann Neurol, 2023, 93(2): 297-302. doi: 10.1002/ana.26549
[15]	OGAWA R, NAKASHIMA I, TAKAHASHI T, et al. MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy[J]. Neurol Neuroimmunol Neuroinflamm, 2017, 4(2): e322. doi: 10.1212/NXI.0000000000000322
[16]	REINDL M, SCHANDA K, WOODHALL M, et al. International multicenter examination of MOG antibody assays[J]. Neurol Neuroimmunol Neuroinflamm, 2020, 7(2): e674. doi: 10.1212/NXI.0000000000000674
[17]	SECHI, BUCIUC M, PITTOCK S J, et al. Positive predictive value of myelin oligodendrocyte glycoprotein autoantibody testing[J]. JAMA Neurol, 2021, 78(6): 741-746. doi: 10.1001/jamaneurol.2021.0912
[18]	WANG M M, TAN J, ZHOU Z Y, et al. Relapsing MOG-IgG-associated diseases coexisting with anti-NMDAR encephalitis: a case report and literature review[J]. J Integr Neurosci, 2022, 21(3): 82. doi: 10.31083/j.jin2103082
[19]	ZHOU L, ZHANGBAO J Z, LI H Q, et al. Cerebral cortical encephalitis followed by recurrent CNS demyelination in a patient with concomitant anti-MOG and anti-NMDA receptor antibodies[J]. Mult Scler Relat Disord, 2017, 18: 90-92. doi: 10.1016/j.msard.2017.09.023
[20]	BEREK K, GRAMS A, UPRIMNY C, et al. Anti-NMDA receptor encephalitis and MOG-associated demyelination- a case report with long-term follow-up and a systematic review[J]. BMC Neurol, 2022, 22(1): 434. doi: 10.1186/s12883-022-02974-x
[21]	HOU C, WU W L, TIAN Y, et al. Clinical analysis of anti-NMDAR encephalitis combined with MOG antibody in children[J]. Mult Scler Relat Disord, 2020, 42: 102018. doi: 10.1016/j.msard.2020.102018
[22]	PÉREZ C A, AGYEI P, GOGIA B, et al. Overlapping autoimmune syndrome: a case of concomitant anti-NMDAR encephalitis and myelin oligodendrocyte glycoprotein (MOG) antibody disease[J]. J Neuroimmunol, 2020, 339: 577124. doi: 10.1016/j.jneuroim.2019.577124
[23]	徐义君, 符长标, 梁景岩, 等. 1例成人抗N-甲基-D-天冬氨酸受体抗体合并抗髓鞘少突胶质细胞糖蛋白抗体双阳性脑炎病例报告[J]. 实用临床医药杂志, 2021, 25(11): 47-49, 53. doi: 10.7619/jcmp.20210437

Cited By

Cited by

Periodical cited type(60)

1.	蔡莉，杜桂芝. 多层面干预在无痛胃镜检查患者中的临床效果观察. 临床消化病杂志. 2024(04): 280-284 .
2.	孟凡华. 协作式无缝隙全期护理模式辅助内镜下黏膜切除术治疗胃息肉的应用效果. 医学信息. 2023(04): 153-155 .
3.	史娟双. 专科护士主导的可视化健康教育在无痛消化内镜检查中的应用价值. 黑龙江中医药. 2023(03): 175-177 .
4.	崔希茹. 不同护理模式在无痛消化内镜检查术中的应用效果. 医学信息. 2022(05): 184-186 .
5.	傅丽桑，杨媛萍，周秀花. 快速康复理念支持下的护理干预在全胃术后患者中的运用. 中外医疗. 2022(03): 137-141 .
6.	王扬正，吴姗宏，招燕珍. 时空限制突破式交互教育平台在胃肠镜检查患者中的应用研究. 黑龙江医学. 2022(12): 1514-1516 .
7.	施香兰. 预见性护理模式在胃肠镜检查风险控制中的应用. 医学信息. 2022(14): 190-192 .
8.	文银霞. 以人性化理念为基础的综合护理在胃十二指肠镜检查中的应用. 黑龙江医药. 2022(04): 981-983 .
9.	苏雪棠，梁健，周少丹. 医护麻三位一体安全管理措施对清醒镇静麻醉下无痛胃肠镜检查患者负性情绪及不良反应的影响. 吉林医学. 2022(11): 3135-3138 .
10.	李爱敏，范素强，陈玉楠. 无痛胃镜检查中全程服务管理对患者情绪、复查依从性的影响. 河北医药. 2022(21): 3345-3347+3351 .
11.	柏婷婷，王化明，耿晓菁，杨小峰，王旭璞. 针对性认知干预结合预见护理对胃肠镜下手术患者的干预效果. 现代中西医结合杂志. 2022(22): 3183-3186 .
12.	黄金转. 腹腔镜联合胆道镜治疗胆囊结石合并胆总管结石病人的护理观察. 疾病监测与控制. 2021(01): 52-54 .
13.	孙薇. 心理护理干预在无痛胃肠镜检查中的应用分析. 心理月刊. 2021(05): 155-156 .
14.	刘秀玉，任宪辉，侯信良，曾婷. 依托咪酯联合优质护理在无痛胃肠镜检查中的应用效果. 现代医学与健康研究电子杂志. 2021(13): 16-19 .
15.	包萍，成敏，顾政. 护理安全管理措施在清醒镇静麻醉下无痛胃镜及肠镜检查患者中的应用效果. 国际护理学杂志. 2021(14): 2644-2647 .
16.	张薇，石桂梅，王靓. 中医情志护理对行无痛胃镜检查患者麻醉效果及心理性疼痛的研究. 中国当代医药. 2021(26): 262-264+268 .
17.	曾婷，朱洪春，侯信良，刘秀玉. 右美托咪定联合围手术期护理在无痛胃镜检查患者中的应用. 现代医学与健康研究电子杂志. 2021(17): 131-133 .
18.	董洋洋. 优质护理服务在无痛胃肠镜检查中的实施. 中外医疗. 2021(24): 144-147 .
19.	杨霞，何小霞，吴永萍，娄小敏. 探讨全程护理干预在无痛胃镜联合肠镜检查中的应用. 中国社区医师. 2021(32): 161-162+165 .
20.	杨小敏，黄小洁，林雪华，曾楚云. 优质护理干预在无痛胃肠镜诊疗患者中的应用效果观察. 智慧健康. 2021(28): 150-152 .
21.	潘锦梅. 流程化护理在无痛胃肠镜检查中的应用效果. 医学食疗与健康. 2021(10): 133-134 .
22.	成洁. 全程护理干预对无痛胃镜检查患者负性情绪及并发症的影响. 医疗装备. 2020(01): 189-191 .
23.	胡水娟，王雅琴，闫琴芬. 人性化沟通在缓解胃肠镜检查患者负性情绪中的应用. 齐鲁护理杂志. 2020(04): 108-110 .
24.	万小艳. 全程优质护理配合支气管动脉栓塞对咳血患者病情转归及不良反应的影响. 医疗装备. 2020(05): 185-186 .
25.	段鲁静，赵作静，王瑞，马建民. 优质护理干预对老年无痛胃肠镜诊疗术患者生命体征、情绪及不良反应的影响. 航空航天医学杂志. 2020(01): 96-98 .
26.	刘丽芳. 全程整体护理在无痛胃肠镜诊疗胃肠疾病患者中的应用. 中西医结合心血管病电子杂志. 2020(04): 120 .
27.	卓傲. PDCA模式在胃肠镜检查中护理风险控制的应用效果. 临床医药文献电子杂志. 2020(24): 124 .
28.	林翠香，司徒丽萍，张宁，陈秀迎. 优质护理对接受无痛胃肠镜检查患者检查时间及并发症发生率的影响. 当代医药论丛. 2020(12): 218-219 .
29.	曾海云. 优质护理在无痛胃肠镜诊疗患者中的应用研究. 中国医药指南. 2020(24): 15-16+19 .
30.	毛红玲，吴杨玲，魏小飞，代浩，杨雪，付羽婷. 体位护理联合心理干预对无痛胃肠镜检查患者生命体征及心理状态的影响. 实用医院临床杂志. 2020(05): 193-195 .
31.	葛耐耐. 语言沟通应用于无痛胃镜检查护理中对患者并发症发生率及满意度的影响. 中国社区医师. 2020(34): 134-135 .
32.	张莉. 精细健康干预对行无痛胃肠镜诊疗患者的临床应用价值. 智慧健康. 2020(30): 156-157 .
33.	吴诗虹. 优质护理干预在电子无痛胃肠镜诊疗中的应用效果. 临床合理用药杂志. 2019(03): 171-173 .
34.	郑瑶珍，衷爱华，李春梦. 全程护理干预对无痛胃镜联合肠镜检查患者的效果. 中国医药科学. 2019(04): 127-129 .
35.	黄冬梅. 舒适护理对无痛消化内镜检查患者心理状况及护理质量的影响. 名医. 2019(03): 210 .
36.	李燕，谢娟，巫丽莎. 流程化护理干预对胃肠镜检查术患者负性心理的影响观察. 实用临床护理学电子杂志. 2019(11): 2-3 .
37.	张小荣，卢伟丽. 综合心理护理在呼吸内镜治疗患者中的应用效果. 当代护士(中旬刊). 2019(09): 101-103 .
38.	金笑笑. 全程护理在电子胃镜检查中的应用. 世界最新医学信息文摘. 2019(70): 367-368 .
39.	陈斌斌，陈新妹. 围术期全程优质护理对无痛胃肠镜检查患者负性情绪及术中麻药用量的影响. 中外医学研究. 2019(26): 104-106 .
40.	刘乃真，谢文吉. 健康教育联合心理护理在无痛胃镜中的护理干预效果. 中外医学研究. 2019(28): 83-85 .
41.	赵云霞. 优质护理在无痛胃肠镜麻醉患者中的应用体会. 实用临床护理学电子杂志. 2019(42): 143 .
42.	王丽君，顾晓燕. 优质护理对结肠癌患者围手术期护理效果的影响. 实用临床护理学电子杂志. 2019(41): 125 .
43.	李艳艳. 对接受无痛肠镜检查的患者进行全程精细化护理的效果探讨. 当代医药论丛. 2019(19): 238-239 .
44.	周峰. 对接受甲状腺肿瘤切除术的患者进行全程优质护理的效果探析. 当代医药论丛. 2019(22): 275-277 .
45.	孟兴宇，孙婉婷. 对进行无痛胃肠镜检查的胃肠疾病患者实施优质护理的应用. 临床医药文献电子杂志. 2019(93): 155 .
46.	周燕妮，闫琳. 优质护理带教法在无痛胃肠镜检查中的应用价值. 内蒙古医科大学学报. 2019(S2): 252-254 .
47.	万敏. 对进行无痛胃肠镜检查的胃肠疾病患者实施优质护理的效果分析. 当代医学. 2018(19): 177-178 .
48.	熊合明，金晓英. 综合护理干预对中青年结直肠镜检查患者心理状况的影响. 护理实践与研究. 2018(08): 152-154 .
49.	刘善红，朱金早，谭金娉，罗子青，徐建晶. 探究在无痛胃肠镜诊疗中采用精细护理干预的效果. 护理实践与研究. 2018(15): 138-139 .
50.	刘春燕，吴娟，吴慧娟. 全程整体护理应用于无痛胃肠镜诊疗胃肠疾病患者中的效果分析. 中外医疗. 2018(12): 155-157 .
51.	罗子青，肖文鑫. 预见性护理在无痛胃肠镜麻醉患者中的应用. 内蒙古医学杂志. 2018(06): 759-760 .
52.	刘佳. 全程护理干预对胃肠镜检查患者心理状态及生命体征的影响. 医疗装备. 2018(18): 172-173 .
53.	孙国明，占文娟. 4R危机管理模式在无痛胃肠镜检查风险管理中的应用. 中医药管理杂志. 2018(17): 164-165 .
54.	王军花，张利，周艳. 流程化护理干预对胃肠镜检查术患者心理的影响. 中国现代药物应用. 2018(22): 164-165 .
55.	赵君君. 对接受无痛胃肠镜检查的患者进行预警性护理的效果评价. 当代医药论丛. 2018(21): 254-255 .
56.	温林芳. 围手术期全程优质护理在无痛胃肠镜检查患者中的应用. 医疗装备. 2018(23): 197-198 .
57.	段旭娟. 强化心理护理联合健康指导在无痛胃肠镜检查前中的应用. 中西医结合心血管病电子杂志. 2018(35): 141-142 .
58.	李永霞. 全程护理对无痛胃镜检查患者生命体征及心理状态的影响评价. 心理月刊. 2018(11): 54 .
59.	缪愿戍. 优质护理干预ICU肿瘤重症患者的效果评价. 中国继续医学教育. 2018(32): 170-172 .
60.	常慧莉，韩俊萍. xx例无痛胃肠镜患者的护理管理分析. 中国妇幼健康研究. 2017(S4): 196-197 .

Other cited types(1)

Get Citation

PDF

XML

Article views PDF downloads Cited by(61)

Turn off MathJax

Article Contents

Abstract

References

Analysis of three encephalitis cases with double positive for N-methyl-D-aspartate receptor and myelinating oligodendrocyte glycoprotein antibodies

Abstract

References

Cited by

Periodical cited type(60)

Other cited types(1)

Catalog

Export File

Citation

Format

Content